Reconciling art and science in the era of personalised medicine: the legacy of George Canguilhem
Published version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Abstract
Abstract Background Biomedicine, i.e. the application of basic sciences to medicine, has become the cornerstone for the study of etiopathogenesis and treatment of diseases. Biomedicine has enormously contributed to the progress of medicine and healthcare and has become the preferred approach to medical problems in the West. The developments in statistical inference and machine learning techniques have provided the foundation for personalised medicine where clinical management can be fully informed by biomedicine. The deployment of precision medicine may impact the autonomy and self-normativity of the patients. Understanding the relationship between biomedicine and medical practice can help navigate the benefits and challenges offered by precision medicine.
Methods
Conventional content analysis was applied to “Le Normal and le Pathologique” (Canguilhem G. The Normal and the Pathological. Princeton: Princeton University Press; 1991) and further investigated with respect to its relationship with techne and precision medicine using PubMed and Google Scholar and the Standford Encyclopedia of Philosophy to search for the following keywords singularly or in combination: “Canguilhem”, “techne”, “episteme”, “precision medicine”, “machine learning AND medicine”.
Results
The Hippocratic concept of techne accounts for many characteristics of medical knowledge and practice. The advances of biomedicine, experimental medicine and, more recently, machine learning offer, in contrast, the model of a medicine based purely on episteme. I argue that Canguilhem medical epistemology establishes a framework where episteme and data-driven medicine is compatible with the promotion of patient’s autonomy and self-normativity.
Conclusions
Canguilhem’s medical epistemology orders the relationship of applied medicine with experimental sciences, ethics and social sciences. It provides guidance to define the scope of medicine and the boundaries of medicalization of healthy life. Finally, it sets an agenda for a safe implementation of machine learning in medicine.
Description
Acknowledgements: I’d like to thank the Von Hügel Institute Artificial Intelligence working group. In particular, I am grateful to Vittorio Montemaggi, Philip McCosker, Maria Burke, Gill Goulding, John Warner and Lidia Ripamonti for comments and helpful discussions. I would also like to thank the anonymous reviewers for their insightful comments and feedbacks.
Funder: Cancer Research UK; doi: http://dx.doi.org/10.13039/501100000289
Journal Title
Conference Name
Journal ISSN
1747-5341

